Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Press release cover image

Oct 31, 2026

Press release

Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.

SHANGHAI, Oct. 31, 2026 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma") announced today that its independently developed next-generation potassium channel opener, CB03-154, intended for the treatment of amyotrophic lateral sclerosis (ALS), has successfully completed patient enrollment in its pivotal Phase 2/3 clinical trial, in total enrolled 255 patients. This significant milestone marks the entry of the critical stage in the clinical development of CB03-154 for ALS in C
A minimalist illustration of a stethoscope and circuit board representing clinical AI accountability.

Oct 31, 2026

Who’s responsible when clinical AI goes wrong? AMA weighs in

The American Medical Association (AMA) has recently expanded its guidance on the responsibilities associated with clinical AI, addressing critical liability issues that current frameworks inadequately cover.The AMA's latest framework emphasizes the need for clear delineation of accountability among various stakeholders when clinical AI systems malfunction. It highlights that existing liability structures may leave healthcare providers vulnerable to risks they cannot control, while patients face
A minimalist illustration of a test tube representing scientific research.

Oct 31, 2026

Google launches Singapore research hub to advance life sciences and healthcare with local talent

Google is enhancing its presence in Singapore by establishing a new research hub aimed at advancing healthcare and life sciences through local talent development and innovative AI applications.The recently announced research hub will comprise a team of scientists and software engineers dedicated to improving AI efficiency and supporting academic institutions like the National University of Singapore and Nanyang Technological University. This initiative is part of Google's broader commitment to b
A vial of personalized cancer vaccine EVX-01 in a laboratory setting

Oct 31, 2026

Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

Evaxion has been awarded the prestigious International Prix Galien Award for its innovative AI-Immunology™ platform, recognized as the best digital health solution.This accolade, presented at the American Museum of Natural History in New York City, underscores the significance of AI-Immunology™, which employs artificial intelligence to decode the human immune system, paving the way for novel immunotherapies targeting cancer, autoimmune, and infectious diseases. The platform has already demonstra
Press release cover image

Oct 30, 2026

Press release

Orbis International commits to helping improve eye health for more than 18 million people

Global commitment announced during the first Global Summit for Eye Health will strengthen the global eye health workforce, expand quality cataract care, and implement AI screeningNEW YORK, Oct. 30, 2026 /PRNewswire/ -- Global eye care nonprofit Orbis International is committing an estimated US$32 million in financial and technical contributions from 2027 through 2030 to help strengthen eye health systems and expand access to quality eye care. The commitment aims to contribute to better eye healt
A robotic pipette in a laboratory setting, ready to dispense a liquid sample.

Oct 30, 2026

Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure

Opentrons Labworks has successfully secured $40 million in a Series E funding round, aimed at enhancing its robotics and software capabilities in the life sciences sector.The financing, led by Avego and supported by BroadOak Capital Partners, will primarily focus on advancing Opentrons' artificial intelligence and robotics systems. The company plans to leverage these funds to improve experimental execution and broaden its automation features, thereby facilitating the development of faster and mo
A minimalist representation of an immune cell and RNA-seq profile in a dark color scheme.

Oct 30, 2026

100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic

Parse Biosciences and Nomic Bio have partnered to create Cascade, an extensive dataset aimed at enhancing understanding of the human immune response through a combination of single-cell and proteomic data.The Cascade dataset, consisting of 100 million single-cell RNA-seq profiles and over 11,000 proteomic secretome profiles, aims to provide pharmaceutical companies with a comprehensive view of immune biology. This multimodal dataset captures the responses of various immune cell types to more tha
Press release cover image

Oct 30, 2026

Press release

Amid Widespread Pharmacy Software Consolidation, Datascan Commits to Remaining Independent

After years of acquisition interest, the family-owned pharmacy technology company says it will not sell to a private-equity or corporate consolidator—preserving long-term choice, personal service and vendor freedom for independent pharmaciesBOHEMIA, N.Y., Oct. 30, 2026 /PRNewswire/ -- Following more than a decade of acquisitions, corporate consolidation, ownership changes and discontinued software platforms across the pharmacy software industry, Datascan announced a long-term commitment to remai
A vial of drug compound on a lab bench with a microscope in the background.

Oct 30, 2026

Dimension's Simon Barnett: AI Lets Biotech Teams Run a Dozen Drug Programs, but "We Only Have So Many Monkeys"

Simon Barnett, head of research at Dimension, emphasizes that advances in AI are revolutionizing biotech, allowing small teams to manage significantly more drug programs than previously possible.In a recent discussion, Barnett highlighted the transformative impact of AI on biotech operations, stating that modern technology enables teams to handle up to a dozen drug programs at once. This shift is not merely about reducing staffing costs; rather, it redefines the capabilities and structure of bio
Press release cover image

Oct 30, 2026

Press release

Los Angeles Oral and Maxillofacial Surgeon Dr. David Salehani Uses Live 3D Navigation to Plan and Place Full-Arch All-on-X Dental Implants

Board-certified oral and maxillofacial surgeon David Salehani, DDS, MD, combines CBCT-based digital planning with X-Guide live navigation for patients replacing a full arch of missing or failing teeth with All-on-X dental implants at Sunset Oral and Facial Surgery. The approach offers patients who wear dentures, or who have been told they lack the bone for implants, a fixed full-arch option planned around their own anatomy.WEST HOLLYWOOD, Calif., Oct. 30, 2026 /PRNewswire/ -- Sunset Oral and Fac
A flat design of a medical file icon representing electronic health records.

Oct 30, 2026

VA completes new EHR deployments in Ohio and Alaska

The U.S. Department of Veterans Affairs has successfully launched the Oracle Health electronic health record (EHR) system in Ohio and Alaska, marking a significant step in the Federal Electronic Health Record Modernization program.This recent deployment includes the Louis Stokes Cleveland VA Medical Center and the Alaska VA Healthcare System, along with 16 associated clinics. The initiative aims to streamline the transfer of military health records among various federal partners and integrate in
Press release cover image

Oct 30, 2026

Press release

Neurocrine Biosciences Launches Interactive Educational Resources to Support Clinical Learning in Classic Congenital Adrenal Hyperplasia

BootCAHmp® delivers evidence-based education to strengthen understanding of classic congenital adrenal hyperplasia through interactive learning and real-world patient casesDiscoverCAH™ provides immersive virtual experiences to expand knowledge of classic congenital adrenal hyperplasia through realistic patient scenariosSAN DIEGO, Oct. 30, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the launch of educational resources designed to help healthcare providers stre